Press Releases Medicare Could Save $14 Billion with Access to Ozempic and Wegovy Generics September 24, 2024
Press Releases Three Facts to Know Before Novo Nordisk CEO Testifies at Senate Committee Hearing September 19, 2024
Press Releases First round of Medicare Drug Price Negotiations Promising Steps against Pharma Profiteering August 14, 2024
Press Releases Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare Solvency August 7, 2024
Press Releases Public Citizen Urges HHS to Unlock Generic Competition for Popular Weight Loss Drugs Ozempic and Wegovy August 5, 2024